Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

109
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
109
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measuring and Modeling Air Pollution and Noise Exposure Near Unconventional Oil and Gas Development in Colorado.

Research report (Health Effects Institute)·2026
Same author

[Experience summary of robot-assisted laparoscopic transplant nephrectomy].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2025
Same author

[Efficacy of rigid ureteroscopic laser lithotripsy combined with N-trap in the treatment of ureteral stones with a maximum diameter equal to or greater than 1.5 cm].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2025
Same author

Preparation and characterisation of novel casein-gum Arabic composite microcapsules for targeted in vivo delivery of Lactiplantibacillus plantarum A3.

Beneficial microbes·2024
Same author

Quantifying hospital environmental ventilation using carbon dioxide monitoring - a multicentre study.

Anaesthesia·2023
Same author

Major Fusarium species and mycotoxins associated with freshly harvested maize grain in Uruguay.

Mycotoxin research·2023

Related Experiment Video

Updated: Apr 1, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.2K

Combinatorial therapy for triple negative breast cancer using hyperstar polymer-based nanoparticles.

S K Misra1, X Wang, I Srivastava

  • 1Department of Bioengineering, Beckman Institute for Advanced Science and Technology, Materials Science and Engineering, Carle Foundation Hospital, University of Illinois at Urbana-Champaign, and Carle Foundation Hospital, 502 N. Busey, Urbana, USA. dipanjan@illinois.edu.

Chemical Communications (Cambridge, England)
|October 6, 2015
PubMed
Summary

A new nanoparticle drug combination effectively targets triple-negative breast cancer (TNBC) by inhibiting key pathways. This nano-cocktail shows significantly improved efficacy and selectivity compared to individual drugs.

More Related Videos

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.6K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.6K

Related Experiment Videos

Last Updated: Apr 1, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.2K
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
09:01

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

3.6K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.6K

Area of Science:

  • Nanotechnology
  • Oncology
  • Pharmacology

Background:

  • Triple-negative breast cancer (TNBC) presents a significant therapeutic challenge due to limited targeted treatment options.
  • STAT3 and topoisomerase-II are critical signaling and DNA-processing pathways implicated in TNBC proliferation.

Purpose of the Study:

  • To develop and evaluate a novel nanoparticle-based combinatorial therapy for selective targeting of TNBC.
  • To investigate the efficacy of this nano-cocktail in inhibiting TNBC cell proliferation via STAT3 and topoisomerase-II pathways.

Main Methods:

  • Formulation of a nano-cocktail using hyperstar polymer nanoparticles encapsulating therapeutic drugs.
  • Assessment of the selective targeting and anti-proliferative effects of the nano-cocktail on TNBC cells.
  • Comparative analysis of the combinatorial therapy's efficacy and selectivity against individual drugs.

Main Results:

  • The novel nanoparticle combinatorial therapy demonstrated selective targeting of TNBC cells.
  • The nano-cocktail significantly inhibited TNBC cell proliferation by modulating STAT3 and topoisomerase-II pathways.
  • Efficacy was 2-4 fold higher, and selectivity was 6-20 times greater than the parent drugs alone.

Conclusions:

  • This hyperstar polymer nanoparticle-based nano-cocktail represents a promising targeted therapy for triple-negative breast cancer.
  • The combinatorial approach offers enhanced efficacy and selectivity, potentially overcoming limitations of current treatments.